A study of oral metformin for the intravesical treatment of non‐muscle‐invasive bladder cancer
We did not find conclusive evidence for the hypothesis of an antitumour effect of metformin in bladder cancer.
Authors
- C. Dilara Savci‐Heijink (ORCID: https://orcid.org/0000-0003-1220-0061)
- Theo M. de Reijke (ORCID: https://orcid.org/0000-0003-0651-7361)
- Michaël Pollak (ORCID: https://orcid.org/0000-0003-3047-0604)
- Jorg R. Oddens (ORCID: https://orcid.org/0000-0002-6079-5613)
- Hanneke Wilmink
- J Van Hattum (ORCID: https://orcid.org/0000-0003-0528-9512)
- Ron A. A. Mathôt (ORCID: https://orcid.org/0000-0001-8401-0879)
- J. Alfred Witjes (ORCID: https://orcid.org/0000-0003-0059-3857)
- Siberyn T. Nuijens (ORCID: https://orcid.org/0000-0003-0425-6479)
- Ben Max de Ruiter
- Gerrit K. Hooijer (ORCID: https://orcid.org/0000-0002-8993-7101)
- Marinka J. Remmelink (ORCID: https://orcid.org/0000-0002-3118-5373)
- Remco J. Molenaar (ORCID: https://orcid.org/0000-0001-5651-3997)
Institutions
- Radboud University Nijmegen (NL)
- Jewish General Hospital (CA)
- Radboud University Medical Center (NL)
- Amsterdam University Medical Centers (NL)
- Cancer Center Amsterdam (NL)
- McGill University (CA)
- University of Amsterdam (NL)
Publication Details
- Journal
- British Journal of Urology
- Published
- 2025-05-22
- DOI
- https://doi.org/10.1111/bju.16767
- Primary Topic
- Metabolism, Diabetes, and Cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Amsterdam University Medical Centers
- ZonMw